• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Annals of xcience and technology policy >1 Introduction
【24h】

1 Introduction

机译：1介绍

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Society benefits from the technology transfer of inventions created by the publicly financed and publicly performed research and development (R&D) within the laboratories of U.S. federal agencies.~1 This study describes in detail an important example-the technology transfer of the invention of the drug-eluting coronary stent within the laboratories of the National Institute of Aging (NIA) within the National Institutes of Health (NIH). Society also benefits from the biomedical innovations developed by industry that do not originate with inventions in federal laboratories but nonetheless receive substantial support from public funding for the R&D investment. The example of Remdesivir, developed by the pharmaceutical company Gilead Sciences and used as a treatment for Covid-19, is used to illustrate the case where the invention occurs in industry yet receives substantial public-sector funding to support the R&D that results in the innovation.
机译：社会福利的技术转让发明创造的公开和资助公开进行研究和开发(研发)在美国联邦的实验室机构。重要的技术转让发明的药物洗脱冠状动脉支架在研究所的实验室衰老的国立中(NIA)卫生研究院(NIH)。生物医学创新开发的行业不产生发明的联邦吗实验室但是获得可观研发的公共资金的支持投资。由基科学和制药公司用作治疗Covid-19,用于说明发明的情况发生行业还收到大量的公共部门资金支持研发的结果创新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号